News

Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with Microsoft which aims to establish a strong ...
Since President Donald Trump announced new tariff policies on April 2, the S&P 500 and Nasdaq Composite each declined about ...
Kenvue Inc. (NYSE: KVUE), maker of consumer ... with a unique quality of multimedia storytelling spanning video, text, photos and graphics.
Johnson & Johnson’s Kenvue – previously the planned New Consumer Health Company – is just one part of the 135-year old company’s plan to reinvigorate its corporate image. The name "Kenvue ...
Katsushika Hokusai’s Japanese woodblock print known as The Great Wave is one of the most famous and widely reproduced images in the ... head of wound care at Kenvue (which was spun off from ...
These would have released third parties such as retailers and J&J’s spin-off company Kenvue from liability, even though these entities had not filed for bankruptcy. The judge also criticised the ...
Owners need to submit photos of their power bank with the word ... sold Benadryl products meant for the Canadian market. Kenvue, the company that sells Benadryl, told DailyMail.com that ...
Image source: Getty Images ... However, at the time of the spin-off, J&J still owned roughly 90% of Kenvue stock, so it remains heavily invested in its major consumer products brands.
Johnson & Johnson JNJ will begin the earnings season for the drug & biotech sector when it reports its first-quarter 2025 ...
Johnson & Johnson’s JNJ first-quarter 2025 earnings came in at $2.77 per share, which beat the Zacks Consensus Estimate of $2.57. Earnings rose 2.2% from the year-ago period. Adjusted earnings exclude ...
Credit: Cristina Arias via Getty Images. A federal judge in Houston has rejected the ... These would have released third parties such as retailers and J&J’s spin-off company Kenvue from liability, ...
The collaboration aims to establish a strong foundation for transforming digital operations through advanced AI technologies.